データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Silo Pharma Reports Promising Preclinical Results in Treating Severe Stress-related Disorders | NASDAQ:SILO
Silo Pharma Shares Are Trading Lower. The Company Announced Results From a Preclinical Study on SPC-15.
Silo Pharma Announces Results From Preclinical Study On SPC-15, Highlighting Proposed Efficacy Of Combining SPC-15 With An NMDAR Antagonist
Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
Silo Pharma Third Quarter 2024 Earnings: US$0.22 Loss per Share (Vs US$0.21 Loss in 3Q 2023)
サイロ・ファーマ | 10-Q:Q3 2024 四半期報告書
データなし
データなし